Safety, Drug Interactions, and Who Should Avoid GLP-1 Off-Label Use for RA GLP-1 therapy is not approved for rheumatoid arthritis, and using it off-label for inflammation alone bypasses proven DMARD therapy
In one case, the FTC found PBMs were billing health plans between $2,000 and $6,000 per month for the cancer drug Imatinib
Staying adequately hydratedparticularly important as gastric motility slowshelps prevent constipation and supports overall metabolic function during this transition
Ipamorelin belongs to a class of peptides known as Growth Hormone Releasing Peptides (GHRPs)
Researchers are investigating whether it could be used as a pain management therapy, especially in individuals who are looking for alternatives to opioid-based treatments
How well your supplement boosts glutathione in your bloodstream directly impacts your immune defenses